Terms: = Prostate cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Staging
170 results:
1. Prognostic Value of PSMA PET/CT in prostate cancer.
Lawal IO; Ndlovu H; Kgatle M; Mokoala KMG; Sathekge MM
Semin Nucl Med; 2024 Jan; 54(1):46-59. PubMed ID: 37482489
[TBL] [Abstract] [Full Text] [Related]
2. Extent of use of artificial intelligence & machine learning protocols in cancer diagnosis: A scoping review.
Dang A; Dang D; Vallish BN
Indian J Med Res; 2023 Jan; 157(1):11-22. PubMed ID: 37040222
[TBL] [Abstract] [Full Text] [Related]
3. [
Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
[TBL] [Abstract] [Full Text] [Related]
4. Beyond diagnosis: is there a role for radiomics in prostate cancer management?
Stanzione A; Ponsiglione A; Alessandrino F; Brembilla G; Imbriaco M
Eur Radiol Exp; 2023 Mar; 7(1):13. PubMed ID: 36907973
[TBL] [Abstract] [Full Text] [Related]
5. Impact of
De Man K; Piron S; Van Laeken N; Delrue L; Fonteyne V; Lumen N; Van den Broeck B; Kersemans K; Ost P; Schelfhout V
Mol Imaging Biol; 2022 Oct; 24(5):750-758. PubMed ID: 35411446
[TBL] [Abstract] [Full Text] [Related]
6. Imaging prostate cancer: Clinical Utility of prostate-Specific Membrane Antigen.
Kuppermann D; Calais J; Marks LS
J Urol; 2022 Apr; 207(4):769-778. PubMed ID: 35085002
[TBL] [Abstract] [Full Text] [Related]
7. Nerve spare robot assisted laparoscopic prostatectomy with amniotic membranes: medium term outcomes.
Noël J; Mascarenhas A; Patel E; Reddy S; Sandri M; Bhat S; Moschovas M; Rogers T; Ahmed S; Stirt D; Patel V
J Robot Surg; 2022 Oct; 16(5):1219-1224. PubMed ID: 35015249
[TBL] [Abstract] [Full Text] [Related]
8. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
9. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
10. prostate zones and cancer: lost in transition?
Ali A; Du Feu A; Oliveira P; Choudhury A; Bristow RG; Baena E
Nat Rev Urol; 2022 Feb; 19(2):101-115. PubMed ID: 34667303
[TBL] [Abstract] [Full Text] [Related]
11. Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue.
Yuan W; Liu B; Sanda M; Wei R; Benicky J; Novakova Z; Barinka C; Goldman R
Prostate; 2022 Jan; 82(1):132-144. PubMed ID: 34662441
[TBL] [Abstract] [Full Text] [Related]
12. A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers.
Hansel DE
Urol Oncol; 2021 Sep; 39(9):582-594. PubMed ID: 34215506
[TBL] [Abstract] [Full Text] [Related]
13. Artificial intelligence is a promising prospect for the detection of prostate cancer extracapsular extension with mpMRI: a two-center comparative study.
Hou Y; Zhang YH; Bao J; Bao ML; Yang G; Shi HB; Song Y; Zhang YD
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3805-3816. PubMed ID: 34018011
[TBL] [Abstract] [Full Text] [Related]
14. hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.
Morozov A; Potoldykova N; Chinenov D; Enikeev M; Glukhov A; Shpikina A; Goryacheva E; Taratkin M; Malavaud B; Enikeev D
Urol Oncol; 2021 Aug; 39(8):498.e21-498.e33. PubMed ID: 33676848
[TBL] [Abstract] [Full Text] [Related]
15. [Silencing ERp29 promotes the invasiveness of human PCa cells in vitro: Molecular mechanisms].
Zhu B; Huang ZC; Deng HH; Dong ZT; Zhao XK; Yang LY; Jiang HY
Zhonghua Nan Ke Xue; 2020 Jul; 26(7):579-587. PubMed ID: 33377711
[TBL] [Abstract] [Full Text] [Related]
16. Human papilloma virus (HPV) integration signature in Cervical cancer: identification of MACROD2 gene as HPV hot spot integration site.
Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
[TBL] [Abstract] [Full Text] [Related]
17. Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
Rodler S; Apfelbeck M; Schulz GB; Ivanova T; Buchner A; Staehler M; Heinemann V; Stief C; Casuscelli J
Eur Urol Focus; 2020 Sep; 6(5):1097-1103. PubMed ID: 32534969
[TBL] [Abstract] [Full Text] [Related]
18. STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Oberhuber M; Pecoraro M; Rusz M; Oberhuber G; Wieselberg M; Haslinger P; Gurnhofer E; Schlederer M; Limberger T; Lagger S; Pencik J; Kodajova P; Högler S; Stockmaier G; Grund-Gröschke S; Aberger F; Bolis M; Theurillat JP; Wiebringhaus R; Weiss T; Haitel A; Brehme M; Wadsak W; Griss J; Mohr T; Hofer A; Jäger A; Pollheimer J; Egger G; Koellensperger G; Mann M; Hantusch B; Kenner L
Mol Syst Biol; 2020 Apr; 16(4):e9247. PubMed ID: 32323921
[TBL] [Abstract] [Full Text] [Related]
19. Pathfinders in oncology from the beginning of modern surgery of intracranial tumors to the introduction of the Pap smear.
Hajdu SI
Cancer; 2020 Jun; 126(12):2734-2749. PubMed ID: 32196649
[TBL] [Abstract] [Full Text] [Related]
20. 64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality?
Cantiello F; Crocerossa F; Cascini GL; Russo GI; Ferro M; Cimino S; Lucarelli G; Damiano R
Minerva Urol Nephrol; 2021 Oct; 73(5):668-671. PubMed ID: 32182228
[TBL] [Abstract] [Full Text] [Related]
[Next]
